Pembrolizumab in Combination With CRT for LA-SCCHN

Clinical trial NCT02586207 · COMPLETED

Trial details

NCT number: NCT02586207
Sponsor: Sanford Health
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Carcinoma Oral Cavity Cancer Oropharynx Cancer Hypopharynx Cancer Larynx Cancer Laryngeal Cancer

Start date: 2015-11-01
Primary completion: 2020-09-29
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.